Fatigue among patients with renal cell carcinoma receiving adjuvant sunitinib or sorafenib: patient-reported outcomes of ECOG-ACRIN E2805 trial

被引：0
作者：
Fengmin Zhao
David Cella
Judith Manola
Robert S. DiPaola
Lynne I. Wagner
Naomi S. B. Haas
机构：
[1] Dana–Farber Cancer Institute,Department of Biostatistics and Computational Biology
[2] Northwestern University,Department of Medical Social Sciences
[3] Rutgers Cancer Institute of New Jersey,Social Sciences & Health Policy Comprehensive Cancer Center
[4] Wake Forest School of Medicine,Abramson Cancer Center
[5] University of Pennsylvania,undefined
来源：
Supportive Care in Cancer | 2018年 / 26卷
关键词：
Fatigue; Patient-reported outcome; Renal cell carcinoma; Adjuvant therapy; Sunitinib; Sorafenib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1889 / 1895
页数：6
相关论文
共 206 条
  • [1] Harding Gale(2007)Symptom burden among patients with Renal Cell Carcinoma (RCC): content for a symptom index Health and Quality of Life Outcomes 5 34-186
  • [2] Cella David(2005)Cytokine therapy: a standard of care for metastatic renal cell carcinoma? Clin Genitourin Cancer 4 181-1668
  • [3] Robinson Don(2001)Interferon-mediated fatigue Cancer 92 1664-134
  • [4] Mahadevia Parthiv J(2007)Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 125-124
  • [5] Clark Jason(2007)Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma New England Journal of Medicine 356 115-731
  • [6] Revicki Dennis A(2013)Pazopanib versus Sunitinib in metastatic renal-cell carcinoma N Engl J Med 369 722-2111
  • [7] Hutson T(2007)Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial Lancet 370 2103-2016
  • [8] Quinn D(2016)Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial The Lancet 387 2008-2254
  • [9] Malik UR(2016)Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy N Engl J Med 375 2246-S54
  • [10] Makower DF(2007)Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects Can Urol Assoc J 1 S41-998
12345678910